Feasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy

Feasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy

Abstract Background Recently, 177Lu-dotatate therapy for neuroendocrine tumours has received regulatory approval. Dosimetry can be used to optimize treatment on an individual basis, but there is no international consensus as to how it should be done. The aim of this study is to determine a feasible...

Full description

Bibliographic Details
Main Authors: Anna Sundlöv, Johan Gustafsson, Gustav Brolin, Nadja Mortensen, Rebecca Hermann, Peter Bernhardt, Johanna Svensson, Michael Ljungberg, Jan Tennvall, Katarina Sjögreen Gleisner
Format: Article
Language:English
Published: SpringerOpen 2018-07-01
Series:EJNMMI Physics
Subjects:
PRRT
Dosimetry
Neuroendocrine
177-Lutetium
Dotatate
SPECT
Online Access:http://link.springer.com/article/10.1186/s40658-018-0210-2

Internet

http://link.springer.com/article/10.1186/s40658-018-0210-2

Similar Items